GOODWILL AND INTANGIBLE ASSETS (Tables)

6 Months Ended

Mar. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Activity of Goodwill by Reportable Operating Segment

The following table reflects the activity of goodwill by reportable operating segment: 

(In millions)	Oncology Systems		Varian Particle Therapy		Total
Balance at September 29, 2017	$	170.2	$	52.4	$	222.6
Business combinations	11.5		—		11.5
Foreign currency translation adjustments	—		2.1		2.1
Balance at March 30, 2018	$	181.7	$	54.5	$	236.2

Schedule of Indefinite-Lived Intangible Assets

The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 

	March 30, 2018							September 29, 2017
(In millions)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Technologies and patents	$	118.0	$	(67.7	)	$	50.3	$	102.0	$	(60.9	)	$	41.1
Customer contracts and supplier relationship	38.2		(16.4		)	21.8		33.9		(14.3		)	19.6
Other	5.7		(4.6		)	1.1		5.5		(3.4		)	2.1
Total intangible with finite lives	161.9		(88.7		)	73.2		141.4		(78.6		)	62.8
In-process research and development with indefinite lives	8.8		—			8.8		8.8		—			8.8
Total intangible assets	$	170.7	$	(88.7	)	$	82.0	$	150.2	$	(78.6	)	$	71.6

Gross Carrying Amount and Accumulated Amortization of Intangible Assets

The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 

	March 30, 2018							September 29, 2017
(In millions)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Technologies and patents	$	118.0	$	(67.7	)	$	50.3	$	102.0	$	(60.9	)	$	41.1
Customer contracts and supplier relationship	38.2		(16.4		)	21.8		33.9		(14.3		)	19.6
Other	5.7		(4.6		)	1.1		5.5		(3.4		)	2.1
Total intangible with finite lives	161.9		(88.7		)	73.2		141.4		(78.6		)	62.8
In-process research and development with indefinite lives	8.8		—			8.8		8.8		—			8.8
Total intangible assets	$	170.7	$	(88.7	)	$	82.0	$	150.2	$	(78.6	)	$	71.6

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

As of March 30, 2018, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):

Fiscal Years:	Remaining Amortization Expense
Remainder of 2018	$	10.9
2019	15.2
2020	12.7
2021	10.4
2022	9.0
Thereafter	15.0
Total remaining amortization for intangible assets	$	73.2